• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Behavioral intervention improved antibiotic prescribing appropriateness

byAnees DaudandShayna Bejaimal
May 4, 2017
in Infectious Disease, Pediatrics, Public Health, Surgery
Reading Time: 2 mins read
Tonsillectomy may have short-term benefits in recurrent throat infection
Share on FacebookShare on TwitterShare on LinkedIn

1. In this prospective stepped-wedge participatory intervention study, implementation of a behavioral antimicrobial stewardship program which maintained prescriber autonomy resulted in improved appropriateness of antimicrobial prescribing in hospitals.

2. Despite the improvement in appropriate antibiotic prescribing practices, there was no decrease in total antimicrobial consumption.

Evidence Rating Level: 2 (Good)

Study Rundown: Minimizing antimicrobial resistance and potential iatrogenic nosocomial infections like C. difficile is predicated on minimizing inappropriate antibiotic use. Changing the prescribing behaviors of practitioners is complex and this prospective, stepped-wedge, participatory intervention study examined whether an antimicrobial stewardship approach grounded in behavioral theory and focus on preserving prescriber autonomy would be effective in improving appropriateness of antimicrobial prescribing in hospitals.

Implementation of the behavioral theory-based antimicrobial stewardship program resulted in an increase in appropriate antimicrobial prescribing by 13% at 12-month follow-up. However, there was no associated decrease in antimicrobial consumption noted. Strengths of this study included investigation of a low-cost, easily implementable intervention to improve appropriate antimicrobial use. However, there was no blinding of the intervention thus awareness of being monitored may have altered prescribers’ behaviors on its own.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

Relevant Reading: A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance

In-Depth [prospective study]: This prospective, stepped-wedge, participatory intervention study was performed October 2011 to December 2015 in 7 clinical departments (2 medical, 3 surgical and 2 pediatric) in one tertiary medical hospital in the Netherlands. Any physician that prescribed any medication for any indication on these seven clinical wards during the study period was included in the study. There was a baseline period and intervention period. The intervention of interest was a stewardship program to help with antimicrobial prescribing that was offered to all physicians of the clinical departments. The stewardship programs were created individually based on root-cause analysis. Appropriateness of antimicrobials was determined using validated approach based on guideline adherence measured 6 times a year with surveys. Pharmacy records determined antimicrobial consumption. Linear and logistic mixed-model regression was used for statistical analysis.

There were a total of 1121 patient cases with 700 antimicrobial prescriptions during the baseline period, and 882 patient cases with 531 antimicrobial prescriptions during the intervention period. Antimicrobial appropriateness increased from 64.1% during the baseline to 77.4% at the 12-month follow-up (relative risk 1.17; 95%CI 1.04-1.27). However, there was no decrease in antimicrobial consumption over the study period.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibioticbehaviorprescriptions
Previous Post

2 Minute Medicine Rewind May 1, 2017

Next Post

Alternate-day fasting not superior than calorie restriction in adults

RelatedReports

A physician converses with a female patient, with elements suggesting technology and healthcare in the background.
Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea
Infectious Disease

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

January 14, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 26, 2026
A stack of textbooks
Career Development

How Long Is the MCAT and Why It Matters for Test-Takers

September 22, 2025
Next Post
Parent/child feeding practices associated with weight status

Alternate-day fasting not superior than calorie restriction in adults

High risk of complications, but low mortality among children with MRSA bacteremia

High risk of complications, but low mortality among children with MRSA bacteremia

Interstitial lung abnormalities linked to greater risk of all-cause mortality

Novel imaging agent could enable pulmonary fibrosis diagnosis and monitoring [PreClinical]

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma
  • Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2
  • WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.